Fluctuations in cognition and alertness in Parkinson's disease and dementia

Neurology

Volumn 63, Issue 8 SUPPL. 3, 2004, Pages

  Serrano, Carolina ^a,b   Garcia Borreguero, Diego ^a  

^a Jimenez Diaz Foundation   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; CYANOCOBALAMIN; MELATONIN; MODAFINIL; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; RIVASTIGMINE;

ALERTNESS; ALZHEIMER DISEASE; ATTENTION; CIRCADIAN RHYTHM; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; EPWORTH SLEEPINESS SCALE; EXCESSIVE DAYTIME SLEEPINESS; HUMAN; LEWY BODY; NEUROLOGIC DISEASE; ONE DAY FLUCTUATION ASSESSMENT SCALE; PARKINSON DISEASE; PHOTOTHERAPY; PRIORITY JOURNAL; RATING SCALE; REVIEW; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE;

EID: 7044239167     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.63.8_suppl_3.s31     Document Type: Review

References (36)

1. Levy G, Schupf N, Tang MX, et al. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 2002;51:722-729.
2. McKeith IG. Spectrum of Parkinson's disease, Parkinson's dementia and Lewy body dementia. Neurol Clin 2000;18:865-902.
3. Rinne JO, Portin R, Ruottinen H, et al. Cognitive impairment and the brain dopaminergic system in Parkinson's disease. Arch Neurol 2000; 57:470-475.
4. Aarsland D, Tandberg E, Larsen JP, Cummings JL. Frequency of dementia in Parkinson disease. Arch Neurol 1996;53:538-542.
5. Green J, Mc Donald MW, Vitek JL, et al. Cognitive impairments in advanced PD without dementia. Neurology 2002;59:1320-1324.
6. Litvan I, Mohr E, Williams J, et al. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1991;54:25-29.
7. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002;59:1714-1720.
8. Ondo WG, Dat Vuong K, Khan H, et al. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001;57:1392-1396.
9. Olanow CW, Schapira AH, Roth T. Waking up to sleep episodes in Parkinson's disease. Mov Disord 2000;15:212-215.
10. Schapira AH. Sleep attacks (sleep episodes) with pergolide. Lancet 2000;355:1332-1333.
11. Montastruc JL, Brefel-Courbon C, Senard JM, et al. Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clin Neuropharmacol 2001;24:181-183.
12. García-Borreguero D, Schwarz C, Larrosa O, et al. L-dopa-induced excessive daytime sleepiness in Parkinson's disease: a placebo-controlled case with MSLT assessment. Neurology 2003;61:1008-1010.
13. Garcia-Borreguero D, Larrosa O, Bravo M. Parkinson's disease and sleep. Sleep Med Rev 2001;7:115-129.
14. Rye DB, Bliwise DL Dihenia B, Gurecki P. FAST TRACK: daytime sleepiness in Parkinson's disease. J Sleep Res 2000;9:63-69.
15. Pal S, Bhattacharya KF, Agapito C, Chaudhuri K. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 2001;108:71-77.
16. Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs. newer (nonergot) dopamine agonists. Arch Neurol 2004;61:97-102.
17. O'Suilleabhain PE, Dewey RB. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002;59:986-989.
18. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002;58:1544-1546.
19. McKeith LG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113-1124.
20. Walker MP, Ayre GA, Cummings JL, et al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease and vascular dementia. Neurology 2000;54:1616-1625.
21. Ballard C, O'Brien J, Gray A, et al. Attention and fluctuating attention in patients with dementia with Lewy body disease and Alzheimer disease. Arch Neurol 2001;58:977-982.
22. Grace JB, Walker MP, Mckeith IG. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2000;15:1028-1033
23. Johns MW. Daytime sleepiness, snoring and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993;103:30-36.
24. McKeith IG, Ballard CG, Perry RH, et al. Predictive accuracy of clinical diagnostic criteria for dementia with Lewy bodies: a prospective neuropathological validation study. Neurology 1998;50(suppl 4):A181-182.
25. Walker MP, Ayre GA, Cummings JL, et al. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry 2000; 177:252-256.
26. Briel FC, McKeith IG, Barker WA, et al. EEG findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999;66:401-403.
27. Aarsland D, Karslen K. Neuropsychiatric aspects of Parkinson's disease. Curr Psychiatry Rep 1999;1:61-68.
28. McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double blind, placebo-controlled international study. Lancet 2000;356:2031-2036.
29. Ito T, Yamadera H, Ito R, et al. Effects of vitamin B12 on bright light on cognitive and sleep-wake rhythm in Alzheimer-type dementia. Psychiatry Clin Neurosci 2001;55:281-282.
30. Cardinali DP, Brusco LI, Liberczuk C, Furio AM. The use of melatonin in Alzheimer's disease. Neuroendocrinol Lett 2002;23(suppl 1):20-23.
31. Serfaty M, Kennell-Webb S, Warner J, et al. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry 2002;17:1120-1127.
32. Czeisler C, Khalsa SB. The human circadian timing system and sleepwake regulation. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. 3rd ed. Philadelphia: WB Saunders, 2001:353-376.
33. Happe S, Pirker W, Sauter C, et al. Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil. J Neurol 2001;248:632-634.
34. Schapira A. Excessive daytime sleepiness in Parkinson's disease. Neurology 2004;63:S24-S27.
35. McKeith IG, Burn DJ, Ballard CG, et al. Dementia with Lewy bodies. Semin Clin Neuropsychiatry 2003;8:46-57.
36. Bruguerolle B, Simon N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin Neuropharmacol 2002;25:194-201.